NCT00171028View on ClinicalTrials.gov

A Study Of Valsartan Used To Treat Hypertension For Up To 56 Weeks In Children Ages 1 - 5 Years Who Have Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Hypertension
Interventions
DRUG

valsartan

Trial Locations (1)

07936

Novartis Pharmaceuticals, East Hanover

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY